Mobile Medical Apps: Dangers and Potential Solutions

Visser BJ , Bui]ink AW. Need to peer-review medical applications for smart phones. J Telemed Telecare 2012; 18: 124

Payne KF , Wharrad H , Watts K. Smartphone and medical related App use among medical students and junior doctors in the United Kingdom (UK): a regional survey. BMC Med Inform Decis Mak 2012; 12: 121

Walsworth DT. Medical apps: making your mobile device a medical device. Fam Pract Manag 2012; 19: 10–3.

Nolan T. A smarter way to practise. BMJ 2011; 342: d1124

Hamilton AD , Brady RR. Medical professional involvement in smartphone ‘apps’ in dermatology. Br J Dermatol 2012; 167: 220–1.

Rosser BA , Eccleston C. Smartphone applications for pain management. J Telemed Telecare 2011; 17: 308–12.

Spurling GK , Mansfield PR , Montgomery BD. Information from pharmaceutical companies and the quality, quantity, and cost of physicians’ prescribing: a systematic review. PLoS Med 2010; 7: e1000352.

Stelfox HT , Chua G , O'Rourke K , Detsky AS. Conflict of interest in the debate over calcium-channel antagonists. N Engl J Med 1998; 338: 101–6.

Pharmafile. Digital Pharma Directory - mobile apps. See http://www.inpharm.com/digital-pharma-blog/links/mobile-apps (last checked 10 January 2013)

US Food and Drug Administration. Draft Guidance for Industry and Food and Drug Administration Staff - mobile medical applications. See http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/ucm263280.htm (last checked 10 January 2013)

Association of the British Pharmaceutical Industry. Code of Practice for the Pharmaceutical Industry Second 2012 Edition. Available from http://www.abpi.org.uk/our-work/library/guidelines/Pages/code-2012.aspx (last checked 10 January 2013)

O'Neill S , Brady RR. Clinical involvement and transparency in medical apps; not all apps are equal. Colorectal Dis 2013; 15: 122

Psaty BM. Conflict of interests, disclosure and trial reports. JAMA 2009; 301: 1477–1479.